The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $14,822 purchase order to Central Brain Tumor Registry of the United States for laboratory testing services. The firm fixed price contract has a period of performance from September 1, 2023 through December 31, 2023. The place of performance will be in Hinsdale, Illinois. The National Cancer Institute supports research related to cancer causes, prevention, diagnosis, and treatment...
This is a $240,000 firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to the Central Brain Tumor Registry of the United States (CBTRUS), a non-profit organization. The contract is for a study on malignant and non-malignant brain tumors, with a period of performance from September 30, 2023 to September 29, 2027. CBTRUS, which serves as the nation's largest centralized brain tumor clinical registry, will provide data collection, analysis, and...
This is a $149,997 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to the Central Brain Tumor Registry of the United States (CBTRUS), a non-profit organization. The contract is for data collection, evaluation, and analysis of brain and central nervous system functions. CBTRUS is a comprehensive brain tumor registry that supports various government health agencies through specialized laboratory testing, data collection, and analysis...
This is a definitive, firm-fixed price contract awarded by the Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) to the Central Brain Tumor Registry of the United States (CBTRUS), a non-profit organization, for data collection, evaluation, and analysis of brain and central nervous system malignant and non-malignant tumors. The contract has a potential value of $240,000.00 and a completion date of September 29, 2023. CBTRUS, as the prime contractor, will...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $18,922 firm fixed price purchase order to Baylor College of Medicine for testing services. The contract has a period of performance from November 8, 2023 through January 8, 2024 and will be performed in Houston, Texas. No major subcontractors or set aside designations were indicated. The National Cancer Institute is the federal agency responsible for cancer research within the United...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,520 purchase order to Human Metabolome Technologies America, Inc. for laboratory testing services. The firm fixed price contract has a period of performance from August 22, 2023 through November 21, 2023 for work to be conducted in Boston, Massachusetts. No subcontractors or set aside designations were identified. The award provides laboratory testing support for the National...
<p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to C S Bio Co., a Minority Owned Business, Subchapter S Corporation, for $18,175.00 in laboratory testing services. The contract has an anticipated completion date of August 31, 2024 and was awarded on April 1, 2024. The services will be performed in Bethesda, Maryland. No set-aside was used for this award.</p>
The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $16,265 purchase order to Capralogics Inc. for testing services. The firm fixed price contract will be performed in Hardwick, Massachusetts over a three-month period from July 1, 2023 through September 30, 2023. As the intramural research program of the NCI, a component of the NIH focused on cancer research, this contract supports the agency's mission to lead the nation's...
<p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $17,640 purchase order to Human Metabolome Technologies America, Inc. for testing services. The firm fixed price contract will be performed in Boston, Massachusetts over a three month period concluding in October 2023. The award provides testing services in support of the National Cancer Institute's research efforts. No subcontractors or set aside designations were identified.</p>
The National Cancer Institute (NCI) awarded a $114,883.27 cost-plus-fixed-fee delivery order contract to the North American Association of Central Cancer Registries, Inc. (NAACCR) for the "Enhancing Global Cancer Registry-Centered Surveillance (Global CR-CS) Project." This delivery order is part of a larger $16 million indefinite-delivery, indefinite-quantity (IDIQ) contract with NAACCR to provide support services in developing and promoting methods and standards for cancer registry...